A Longitudinal Study Examining Changes in Plasma Atherogenic Index and Its Association with Cardiometabolic Multimorbidity in Older Adults - Takeaways - MDSpire

A Longitudinal Study Examining Changes in Plasma Atherogenic Index and Its Association with Cardiometabolic Multimorbidity in Older Adults

  • By

  • Liangbin Hu

  • Zhengfei Zhao

  • April 1, 2026

  • 0 min

Share

  • 1

    Cardiometabolic multimorbidity (CMM) is the coexistence of two or more disorders like stroke, diabetes, and heart disease, significantly impacting quality of life.

  • 2

    The Atherogenic Index of Plasma (AIP) is a key biomarker for assessing atherosclerotic risk and is linked to cardiovascular disease and mortality.

  • 3

    This study utilizes data from the China Health and Retirement Longitudinal Study to explore the longitudinal relationship between AIP and CMM.

  • 4

    Dynamic changes in AIP from 2011 to 2015 are assessed to determine their predictive value for the risk of developing CMM in older adults.

  • 5

    The study includes 5,401 participants, focusing on the impact of cumulative AIP and its trajectory on the incidence of cardiometabolic multimorbidity.

Original Source(s)

A Longitudinal Study Examining Changes in Plasma Atherogenic Index and Its Association with Cardiometabolic Multimorbidity in Older Adults

  • by Liangbin Hu, Zhengfei Zhao

  • April 1, 2026

Related Content

One-year outcomes of thoracic endovascular stent graft repair for acute type B aortic penetrating ulcer combined with antiplatelet drugs

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

The association between the C-reactive protein-triglyceride glucose index and myocardial injury after acute ischemic stroke: a machine learning analysis of the brain-heart axis